scholarly journals Cloverleaf skull-multiple congenital anomalies syndrome

2020 ◽  
Author(s):  

2000 ◽  
Vol 16 (3) ◽  
pp. 0176 ◽  
Author(s):  
M. C. Esmer ◽  
G. Rodriguez-Soto ◽  
D. Carrasco-Daza ◽  
M. L. Iracheta ◽  
V. Del Castillo


1993 ◽  
Vol 46 (4) ◽  
pp. 460-466 ◽  
Author(s):  
Muin J. Khoury ◽  
Lorenzo Botto ◽  
Grady D. Waters ◽  
Pierpaolo Mastroiacovo ◽  
Eduardo Castilla ◽  
...  




2017 ◽  
Vol 110 (1) ◽  
pp. 5-11 ◽  
Author(s):  
A.J. Agopian ◽  
Jane A. Evans ◽  
Philip J. Lupo


Gene ◽  
2015 ◽  
Vol 559 (1) ◽  
pp. 94-98 ◽  
Author(s):  
Sushil Kumar Jaiswal ◽  
Ashok Kumar ◽  
Akhtar Ali ◽  
Amit Kumar Rai


PEDIATRICS ◽  
1987 ◽  
Vol 80 (1) ◽  
pp. 120-120
Author(s):  
FRANZ W. ROSA ◽  
JUHANA IDANPAAN-HEIKKILA ◽  
RITA ASANTI

To the Editor.— Kaler et al (Pediatrics 1987;79:434-436) provided a case report of hypertrichosis and multiple congenital anomalies with maternal minoxidil use. Reports such as this contribute to alerting national drug safety offices of possible teratologic questions. Maternal drug exposure data, since 1979 when minoxidil was marketed, is available to the Food and Drug Administration (FDA) from 73,000 pregnancies (15,600 birth defects, 4,400 spontaneous abortions, and 53,000 normal outcomes). This yields, in addition to the report by Kaler et al, only two other births with maternal minoxidil exposures:



Sign in / Sign up

Export Citation Format

Share Document